Metacognitive Therapy for Post-concussive Symptoms After Mild Traumatic Brain Injury
Not Applicable
Completed
- Conditions
- Post-Concussive SymptomBrain InjuriesPost-Concussive Syndrome
- Interventions
- Behavioral: Metacognitive therapy
- Registration Number
- NCT02690584
- Lead Sponsor
- Norwegian University of Science and Technology
- Brief Summary
The purpose of this open trial is to investigate the feasibility, acceptability, and effect of metacognitive therapy in patients with prolonged post-concussive symptoms after mild traumatic brain injury.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Metacognitive therapy Metacognitive therapy Metacognitive therapy, one 45-60 min session weekly during 10 weeks.
- Primary Outcome Measures
Name Time Method symptoms assessed by Rivermead Post Concussion Symptoms Questionnaire baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after completed therapy
- Secondary Outcome Measures
Name Time Method Behavior Rating Inventory-Adult version (BRIEF-A) baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Brief Pain Inventory (BPI) baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Conners CPT-III 2 pre-treatment baseline measures, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy D-KEFS Trail Making Test baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Color-Word Interference Test baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy D-KEFS Verbal Fluency baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Symbol Digit Modality Test baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Resilience scale for Adults (RSA) baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy The metacognitive beliefs questionnaire (MCQ-30) baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Fatigue questionnaire (FQ) baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Inventory of Interpersonal Problems 64 (IIP-64) baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Fatigue severity scale (FSS) baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy SF-12 baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Epworth sleepiness scale (ESS) baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Cognitive Attention Syndrome (CAS-1) 3 pre-treatment baseline measures, session to session (10 sessions), immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Insomnia severity Index (ISI) baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Beck Depression Inventory (BDI) 3 pre-treatment baseline measures, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy Beck Anxiety Inventory (BAI) 3 pre-treatment baseline measures, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Trial Locations
- Locations (1)
Psykologisk Institutt, Dragvoll
🇳🇴Trondheim, Norway